ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668257 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668257; 2) Community: the network communities that were significantly associated with the response to NSC 668257; 3) Molecule: the relationships between components within communities and NSC 668257; 4) MDR: the compounds that were significantly associated with the NSC 668257.

NSC Compound Enrichment Correlation
NSC 754242 6-(2-(dimethylamino)ethoxy)-9-methoxy-11H-indeno[1,2-c]quinolin-11-one 0.0273093708703111 0.082376149
NSC 760421 TOLONIUM CHLORIDE 0.0273093708703111 0.29452558
NSC 83223 Silver methanesulfonate (Ag(CH2SO3)) 0.0273093708703111 0.60449413
NSC 88903 Null 0.0273093708703111 0.033320002
NSC 92937 1H-Benzo[a]carbazole-1,4(11H)-dione, 11-methyl- 0.0273093708703111 0.75956031
NSC 113951 6-Bromotoyocamycin 0.0273093708703114 0.43697068
NSC 135371 Null 0.0273093708703114 0.49691321
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0273093708703114 0.62077346
NSC 254681 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) 0.0273093708703114 0.063087532
NSC 255105 GELDANAMYCIN ANALOG 0.0273093708703114 0.69017169
Total:84  Current:55    [First] [Prev] [Next] [Last]